GlobeImmune raises $17.25 million in IPO
Last Updated: 17:52 July 8, 2014
The Louisville-based biopharmaceutical company sold 1.725 million shares of its common stock for $10 each, including 225,000 shares sold pursuant to the exercise of the underwriter's overallotment option.
The gross proceeds amount is prior to the deduction of underwriting discounts and commissions and other offering expenses.
GlobeImmune shares began trading July 2. The share price closed at $12.89 Tuesday, up 12 percent from the previous day's close.
More breaking news...
InDevR receives $3 million SBIR grant
SCL drops 'Exempla' from hospitals names
Ten companies in region received VC in 2Q
The move is part of a rebranding effort for
Boulder-based Orbotix Inc.,